Search results

...erial infections (because of the risk of the patient going into shock from lipid A [[endotoxin]] found in certain Gram-negative organisms). ...ometimes causing complete hearing loss<ref>http://www.american-hearing.org/disorders/bilat/gentamicin_toxicity.html Gentamicin Toxicity] at the American Hearing

The terminal two amino acid residues of the [[murein]] precursor [[lipid II]] consist of [[D-alanine]], which is produced by the enzyme [[alanine ra ...also being trialed as an [[adjuvant]] to [[exposure therapy]] for anxiety disorders (e.g. [[phobias]]<ref name="Davis">{{cite journal |last=Davis |first=Michae

...that could increase the risk of [[lactic acidosis]], including [[kidney]] disorders ([[creatinine]] levels over 150 μmol/l,<ref name="Jones2003">{{vcite journ ...signaling, whole body energy balance, and the metabolism of glucose and [[lipid|fat]]s;<ref>{{vcite journal |author=Towler MC, Hardie DG |title=AMP-activat

...s, medicines used to treat gout and disease modifying agents in rheumatoid disorders== ===Disease modifying agents used in rheumatoid disorders (DMARDs)===

...aak MA |title=beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men |journal=J. Clin. Endocrinol. Metab. |vol ...lock sodium channels predicts their therapeutic use in muscle excitability disorders |journal=Mol. Pharmacol. |volume=63 |issue=3 |pages=659–70 |year=2003 |mo

...an morphine on a milligram-for-milligram basis. Due to the [[lipophilicity|lipid solubility]] of diacetylmorphine, it is able to cross the [[blood-brain bar ...{Citation needed|date=January 2009}} In the presence of pain and the other disorders for which morphine is indicated, a combination of psychological and physiol

...y weight and condition being treated. For the elderly or people with liver disorders, initial dose is at the low end of the range, with the dose being increased * Liver disorders

...m and long-term depleted uranium exposure on open-field behavior and brain lipid oxidation in rats. Increased rates of [[immune system]] disorders and other wide-ranging symptoms, including chronic pain, fatigue and memory

.... Lanolin alcohols are a rich source of [[cholesterol]] (an important skin lipid) and are powerful water-in-oil emulsifiers; they have been used extensively ...ty grades of lanolin are ideally suited to the treatment of dermatological disorders such as [[eczema]] and on open wounds.<ref>MR Arden Jones, I Steel and SM P

...diac output]], [[anemia]], [[sickle cell disease]] and other hematological disorders, [[barometric pressure]], and [[metabolic rate]].<ref>{{cite web|url=http:/ ...hondrial]] [[cytochrome oxidase]], and carbon monoxide causing [[brain]] [[lipid peroxidation]].<ref name="Weaver-NEJM"/><ref name="Toxicology2003-Gorman"/>

...causing potentially permanent [[learning disorder|learning]] and behavior disorders. Symptoms include abdominal pain, headache, [[anemia]], irritability, and ...organic lead, which is probably more toxic than inorganic lead due to its lipid solubility, occur rapidly.<ref name="Timbrell08">{{cite book |author = |tit

[[Autoinflammatory syndromes]] are a group of inherited disorders characterized by bouts of [[inflammation|inflammatory]] [[skin lesion]]s an ...ref><ref>{{cite journal |author=Eming R, Hertl M |title=Autoimmune bullous disorders |journal=Clin Chem Lab Med |volume=44 |issue=2 |pages=144–9 |year=2006 |p

* [[Lipid storage myopathy]] * [[Lysosomal disorders]]

.../ref><ref>{{cite journal | author=Nishizuka Y | title=Protein kinase C and lipid signaling for sustained cellular responses | journal=FASEB J| year=1995 | v Two rare autosomal recessive metabolic disorders characterized by hyperphosphatemia: [[Calcinosis#Tumoral calcinosis|hyperph

** [[Phagocyte disorders]] ** [[Myeloproliferative disorders]]

Phytocannabinoids are nearly insoluble in water but are soluble in [[lipid]]s, [[alcohol]]s, and other non-polar [[organic solvent]]s. However, as [[p ...rotenhermen F. "Cannabinoids." ''Current Drug Targets - CNS & Neurological Disorders''. 2005 Oct;4(5):507-30. PMID 16266285</ref> It is found in nearly all tiss

...unique in that they do not always exhibit outward symptoms. Defining the disorders becomes difficult and so neuroproteomics is a step in the right direction o ...proach dedicated to studying proteomic changes in the field of psychiatric disorders, particularly substance-and drug-abuse neurotoxicity.

...ntalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts | journal = Curr. Biol. | volume = 11 | issue = 16 | pages = 1288–9 ...t APP interacts with [[reelin]], a protein implicated in a number of brain disorders, including Alzheimer's disease.<ref name="pmid19515914">{{cite journal | au

...e therapeutic treatment of Parkinson's disease |journal=CNS & Neurological Disorders Drug Targets |volume=7 |issue=6 |pages=512–23 |year=2008 |month=December ...itle=PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts |journal=EMBO J. |volume=22 |issue=8 |pages=1790–800 |publisher= |l

...y packed around a water-filled pore through the plane of the membrane or [[lipid bilayer]].<ref name="isbn0-87893-741-2">{{cite book | author = Purves,| aut ...of ion channels and have disastrous consequences for the organism. Genetic disorders of ion channels and their modifiers are known as [[Channelopathy|Channelopa

...nd elimination half-life and other chemical characteristics including high lipid solubility and relatively moderate to low molecular weight (identical to mo ...has an identical molecular weight, higher milligram potency, and superior lipid solubility, this method works well and is possible to implement with equipm

...ergency medicine and in the treatment of psychiatric illnesses and seizure disorders. There is no evidence that a single induction dose of etomidate has any ef ...ciception|pain]] on injection, a side effect which is less likely with the lipid formulation.